speb/financial-data huggingface dataset:
Financial ratios for HGM.NS — quarterly report dated 2025-03-31
Total revenue: 644704.2319382745
Gross profit: 167325.22796352583
Operating income: 90413.84147767126
Net income: 154617.72270282908
Capital expenditures: 0
Depreciation & amortization: 29635.258358662613
Net tangible assets: 2812415.244330138
Owner earnings: 184252.9810614917
Return on net tangible assets (%): 6.55141453357387
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.527599486521181
P/E ratio: 10.744403428965821
Shares outstanding: 12594972
Book value: 2812415.244330138
P/B ratio: 2.362773695436779
Market cap (USD): 6645100.759948653
Debt to equity: 0.058406145302484884
Current ratio: 1.585839522707902
Quick ratio: 1.585839522707902
Effective tax rate (%): -12.178998220188152
Interest coverage ratio: 20.460317460317462
COGS to revenue (%): 74.04620294480307
Buyback yield (%): 0
Retained earnings: 2454337.1522094924
Receivables turnover: 0.3596264705115163
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.125101018264102
Revenue growth (%): -4.562013945810281
Rule of 40 score: -4.562013945810281
Financial ratios for HGM.NS — annual report dated 2025-03-31
Total revenue: 2626642.50642974
Gross profit: 622667.7577741407
Operating income: 313829.78723404254
Net income: 492997.42810381105
Capital expenditures: 3308.3937339256486
Operating cash flow: -75274.72527472526
Depreciation & amortization: 138905.77507598783
Net tangible assets: 2812415.244330138
Owner earnings: 628594.8094458733
Return on net tangible assets (%): 22.35071121567584
Capex to operating income (%): 1.0542000372508846
Buffett classification: The Great
Stock price: 0.527599486521181
P/E ratio: 13.478976524294131
Shares outstanding: 12594972
Book value: 2812415.244330138
P/B ratio: 2.362773695436779
Market cap (USD): 6645100.759948653
Debt to equity: 0.058406145302484884
Current ratio: 1.585839522707902
Quick ratio: 1.585839522707902
Effective tax rate (%): 11.935941279506213
Interest coverage ratio: 15.607558139534884
COGS to revenue (%): 76.29415665626684
SG&A to revenue (%): 1.8412607985472866
Free cash flow (dilution-adjusted): -78583.11900865092
Buyback yield (%): 0
Retained earnings: 2454337.1522094924
Receivables turnover: 1.4651837650311708
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.847341199288833
FCF margin (%): -2.9917706279513805
Revenue growth (%): 35.84789911134984
Rule of 40 score: 32.85612848339846
Financial ratios for HGM.NS — quarterly report dated 2025-06-30
Total revenue: 1592440.9080271474
Gross profit: 410472.7357828224
Operating income: 230084.24994149312
Net income: 202082.84577580157
Capital expenditures: 0
Depreciation & amortization: 47975.66112801311
Owner earnings: 250058.50690381468
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6686168967938217
P/E ratio: 16.483004023460683
Shares outstanding: 12594972
Market cap (USD): 8421211.093845075
Effective tax rate (%): 28.125259918489565
Interest coverage ratio: 24.921419518377693
COGS to revenue (%): 74.22367550885443
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 147.0033279042616
Rule of 40 score: 147.0033279042616
Financial ratios for HGM.NS — quarterly report dated 2025-09-30
Total revenue: 2136516.3472378803
Gross profit: 361149.9436302142
Operating income: 54644.87034949267
Net income: 55851.183765501686
Capital expenditures: 0
Depreciation & amortization: 67936.8658399098
Net tangible assets: 760281.848928974
Owner earnings: 123788.04960541149
Return on net tangible assets (%): 16.28186307220072
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.8455467869222096
P/E ratio: 18.790587237426486
Shares outstanding: 12594972
Book value: 2673540.0225479146
P/B ratio: 3.983347178706518
Market cap (USD): 10649638.105975196
Debt to equity: 1.0063716829086247
Current ratio: 1.2685611360772213
Quick ratio: 1.2685611360772213
Effective tax rate (%): 57.0476767327161
Interest coverage ratio: 3.368311327310632
COGS to revenue (%): 83.09631732529854
Buyback yield (%): 0
Receivables turnover: 0.731000671177183
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0806219316980945
Revenue growth (%): 34.16613052755473
Rule of 40 score: 34.16613052755473
Financial ratios for HGM.NS — quarterly report dated 2025-12-31
Total revenue: 1586877.5760276262
Gross profit: 66458.72786008689
Operating income: -358137.4624039211
Net income: -347911.32895176567
Capital expenditures: 0
Depreciation & amortization: 89306.00423303999
Owner earnings: -258605.3247187257
Buffett classification: The Gruesome
Stock price: 0.7555976384092682
P/E ratio: 147.22569275245883
Shares outstanding: 12594972
Market cap (USD): 9516731.099030858
Interest coverage ratio: -7.331812998859749
COGS to revenue (%): 95.81198141154339
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -25.725933336332073
Rule of 40 score: -25.725933336332073
Financial ratios for IGM.TO — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 78596850.3937008
Buffett classification: The Gruesome
Stock price: 28.220472440944885
Shares outstanding: 232454705
Market cap (USD): 6559981596.220473
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IGM.TO — annual report dated 2022-12-31
Total revenue: 2315676470.588235
Gross profit: 1126713235.2941175
Operating income: 742292647.0588235
Net income: 641601470.5882353
Capital expenditures: 27699999.999999996
Operating cash flow: 542404411.7647059
Depreciation & amortization: 76466176.47058824
Net tangible assets: 1395102941.1764705
Owner earnings: 690367647.0588235
Return on net tangible assets (%): 49.485068569681765
Capex to operating income (%): 3.7316818521314135
Buffett classification: The Great
Stock price: 23.191176470588232
P/E ratio: 8.40225331798418
Shares outstanding: 232454705
Book value: 4507229411.764706
P/B ratio: 1.1960558455272507
Market cap (USD): 5390898085.073528
Debt to equity: 1.126169689479255
Current ratio: 4.03377144002722
Quick ratio: 4.03377144002722
Effective tax rate (%): 22.215397622269233
Interest coverage ratio: 8.920052308834185
COGS to revenue (%): 51.34409967866079
SG&A to revenue (%): 2.77615485247609
Free cash flow (dilution-adjusted): 435949264.7058823
Buyback yield (%): 1.5776455678390426
Retained earnings: 2921658823.529412
Receivables turnover: 0.5825781151582003
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.347466774008935
FCF margin (%): 18.826000533448493
Rule of 40 score: 18.826000533448493
Financial ratios for IGM.TO — annual report dated 2023-12-31
Total revenue: 2413915151.5151515
Gross profit: 1174459090.9090908
Operating income: 755939393.9393939
Net income: 873114393.9393939
Capital expenditures: 21790151.515151516
Operating cash flow: 634303030.3030303
Depreciation & amortization: 68593939.39393939
Net tangible assets: 2100741666.6666665
Owner earnings: 919918181.8181818
Return on net tangible assets (%): 43.79016213249361
Capex to operating income (%): 2.882526256714504
Buffett classification: The Great
Stock price: 23.492424242424242
P/E ratio: 6.254535012724391
Shares outstanding: 232454705
Book value: 5091218181.818182
P/B ratio: 1.0726164843042267
Market cap (USD): 5460924547.007576
Debt to equity: 1.0799592822340547
Current ratio: 3.455671637405522
Quick ratio: 3.455671637405522
Effective tax rate (%): 18.79292974746976
Interest coverage ratio: 8.097313176067711
COGS to revenue (%): 51.346297728322654
SG&A to revenue (%): 2.781536846968084
Free cash flow (dilution-adjusted): 517806818.1818181
Buyback yield (%): 0
Retained earnings: 3481530303.030303
Receivables turnover: 0.5811846333998476
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.340959379579345
FCF margin (%): 21.450912135698072
Revenue growth (%): 4.242331870391278
Rule of 40 score: 25.69324400608935
Financial ratios for IGM.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 27.85185185185185
Shares outstanding: 232454705
Market cap (USD): 6474294005.925926
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IGM.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.11888111888112
Shares outstanding: 232454705
Market cap (USD): 7001275625.41958
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IGM.TO — annual report dated 2024-12-31
Total revenue: 2441835664.3356643
Gross profit: 1189973426.5734267
Operating income: 787560839.1608392
Net income: 655551748.2517483
Capital expenditures: 21874825.174825177
Operating cash flow: 763876223.7762238
Depreciation & amortization: 64807692.30769231
Net tangible assets: 2718044755.2447553
Owner earnings: 698484615.3846154
Return on net tangible assets (%): 25.698054236848577
Capex to operating income (%): 2.7775409958338217
Buffett classification: The Great
Stock price: 30.11888111888112
P/E ratio: 10.679973997614777
Shares outstanding: 232454705
Book value: 5503780419.58042
P/B ratio: 1.2720848383615788
Market cap (USD): 7001275625.41958
Debt to equity: 0.9638282955161398
Current ratio: 3.614048887260218
Quick ratio: 3.614048887260218
Effective tax rate (%): 22.500723373649357
Interest coverage ratio: 8.704751157452137
COGS to revenue (%): 51.267259957185715
SG&A to revenue (%): 2.882532772976882
Free cash flow (dilution-adjusted): 680901398.6013986
Buyback yield (%): 1.2233135364160108
Retained earnings: 3420206993.0069933
Receivables turnover: 0.6091703929049376
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.457243663574654
FCF margin (%): 27.88481667895728
Revenue growth (%): 1.156648476355426
Rule of 40 score: 29.041465155312704
Financial ratios for IGM.TO — quarterly report dated 2025-03-31
Total revenue: 632970629.3706294
Gross profit: 573465734.2657343
Operating income: 196693706.2937063
Net income: 164644055.94405594
Capital expenditures: 5369930.06993007
Operating cash flow: 49006993.00699301
Net tangible assets: 2776334265.734266
Owner earnings: 159274125.87412587
Return on net tangible assets (%): 5.736849767691865
Capex to operating income (%): 2.730097556813334
Buffett classification: The Great
Stock price: 29.405594405594403
P/E ratio: 10.37916117546434
Shares outstanding: 232454705
Book value: 5563925174.825176
P/B ratio: 1.2285335546621319
Market cap (USD): 6835468772.902098
Debt to equity: 0.9538762002424961
Current ratio: 3.8877044192657024
Quick ratio: 3.8877044192657024
Effective tax rate (%): 22.816604980969768
Interest coverage ratio: 8.796897479201851
COGS to revenue (%): 9.40089355552904
SG&A to revenue (%): 35.841541935683445
Free cash flow (dilution-adjusted): 34536363.63636364
Buyback yield (%): 0.8059974834807921
Retained earnings: 3444051048.9510493
Receivables turnover: 0.1546158347872817
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6235420289888531
FCF margin (%): 5.456234781494297
Rule of 40 score: 5.456234781494297
Financial ratios for IGM.TO — quarterly report dated 2025-06-30
Total revenue: 667837226.2773722
Gross profit: 607757664.2335765
Operating income: 213376642.3357664
Net income: 181445255.47445256
Capital expenditures: 8910948.905109487
Operating cash flow: 208429927.00729924
Net tangible assets: 3043462043.79562
Owner earnings: 172534306.56934306
Return on net tangible assets (%): 5.669014565864893
Capex to operating income (%): 4.176159493168585
Buffett classification: The Great
Stock price: 30.226277372262768
P/E ratio: 20.30181273446216
Shares outstanding: 232454705
Book value: 5965969343.065693
P/B ratio: 1.17771982820934
Market cap (USD): 7026240389.817517
Debt to equity: 0.9197346556099572
Current ratio: 3.8044324062316526
Quick ratio: 3.8044324062316526
Effective tax rate (%): 22.357086188694332
Interest coverage ratio: 9.061562306261624
COGS to revenue (%): 8.996138531942636
SG&A to revenue (%): 35.68333120203905
Free cash flow (dilution-adjusted): 184879562.04379562
Buyback yield (%): 0.36215648753402135
Retained earnings: 3667382481.7518244
Receivables turnover: 0.15881841378951206
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6968620885533465
FCF margin (%): 27.683326830153334
Revenue growth (%): 5.508406755209338
Rule of 40 score: 33.19173358536267
Financial ratios for IGM.TO — quarterly report dated 2025-09-30
Total revenue: 705634532.3741008
Gross profit: 643625899.2805756
Operating income: 245017266.18705037
Net income: 214667625.89928058
Capital expenditures: 6453237.410071943
Operating cash flow: 235776978.4172662
Net tangible assets: 3577397122.3021584
Owner earnings: 208214388.48920864
Return on net tangible assets (%): 5.82027606583461
Capex to operating income (%): 2.63378883884266
Buffett classification: The Great
Stock price: 35.4748201438849
P/E ratio: 14.705638580092199
Shares outstanding: 232454705
Book value: 6464344604.316548
P/B ratio: 1.2756573722830904
Market cap (USD): 8246288851.474821
Debt to equity: 0.831356152993749
Current ratio: 4.104920032205939
Quick ratio: 4.104920032205939
Effective tax rate (%): 22.58007602195037
Interest coverage ratio: 10.511867650236118
COGS to revenue (%): 8.787641512511826
SG&A to revenue (%): 33.94669015692799
Free cash flow (dilution-adjusted): 217210071.94244605
Buyback yield (%): 0.44161134079213044
Retained earnings: 3698545323.7410073
Receivables turnover: 0.17393796320466695
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8882212955839135
FCF margin (%): 30.782233858601675
Revenue growth (%): 5.6596584630983475
Rule of 40 score: 36.441892321700024
Financial ratios for IGM.TO — quarterly report dated 2025-12-31
Total revenue: 744465693.4306569
Gross profit: -489875182.4817518
Operating income: 253391240.8759124
Net income: 236929197.08029196
Capital expenditures: 14742335.766423356
Operating cash flow: 256665693.4306569
Net tangible assets: 3661949635.036496
Owner earnings: 222186861.3138686
Return on net tangible assets (%): 6.067447219591654
Capex to operating income (%): 5.818013170251133
Buffett classification: The Great
Stock price: 44.31386861313868
P/E ratio: 12.913559370878154
Shares outstanding: 232454705
Book value: 6597287591.240875
P/B ratio: 1.561394302342126
Market cap (USD): 10300967255.875912
Debt to equity: 0.8165844312924888
Current ratio: 4.55213938047977
Quick ratio: 4.55213938047977
Effective tax rate (%): 24.56483241690565
Interest coverage ratio: 10.669268832406184
COGS to revenue (%): 165.80225076917947
SG&A to revenue (%): -84.96496777191891
Free cash flow (dilution-adjusted): 226572992.7007299
Buyback yield (%): 0.9179351999747886
Retained earnings: 3771237956.204379
Receivables turnover: 0.1831910494996866
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7875287396894086
FCF margin (%): 30.434309424875334
Revenue growth (%): 5.503013142782146
Rule of 40 score: 35.93732256765748
Financial ratios for IGM.TO — annual report dated 2025-12-31
Total revenue: 2788930656.934306
Gross profit: 1369485401.459854
Operating income: 920670072.9927007
Net income: 808030656.9343065
Capital expenditures: 35805839.41605839
Operating cash flow: 755467883.2116787
Depreciation & amortization: 71578102.18978101
Net tangible assets: 3661949635.036496
Owner earnings: 843802919.7080292
Return on net tangible assets (%): 23.042450164654422
Capex to operating income (%): 3.8891064743387473
Buffett classification: The Great
Stock price: 44.31386861313868
P/E ratio: 12.748238160861497
Shares outstanding: 232454705
Book value: 6597287591.240875
P/B ratio: 1.561394302342126
Market cap (USD): 10300967255.875912
Debt to equity: 0.8165844312924888
Current ratio: 4.55213938047977
Quick ratio: 4.55213938047977
Effective tax rate (%): 23.173304610703806
Interest coverage ratio: 9.764790586049394
COGS to revenue (%): 50.89568117963744
SG&A to revenue (%): 3.031955056944359
Free cash flow (dilution-adjusted): 667882481.7518247
Buyback yield (%): 2.081910649548353
Retained earnings: 3771237956.204379
Receivables turnover: 0.6862735765180484
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.494795201118738
FCF margin (%): 23.947618779664655
Revenue growth (%): 14.214510733386062
Rule of 40 score: 38.162129513050715
Financial ratios for IMAX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.84
Shares outstanding: 54842114
Market cap (USD): 978383313.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMAX — annual report dated 2022-12-31
Total revenue: 221180147.05882353
Gross profit: 114966911.76470588
Operating income: -267647.0588235294
Net income: -14615441.176470587
Capital expenditures: 20755147.05882353
Operating cash flow: 12736029.411764706
Depreciation & amortization: 41662500
Net tangible assets: 126856617.64705881
Owner earnings: 6291911.764705885
Buffett classification: The Gruesome
Stock price: 14.66
Shares outstanding: 54842114
Book value: 242476470.58823532
P/B ratio: 3.315725395085029
Market cap (USD): 803985391.24
Debt to equity: 0.7976001310011885
Current ratio: 1.8063900887111637
Quick ratio: 1.6800387860914998
Interest coverage ratio: -0.06193636208950144
COGS to revenue (%): 48.02114326557072
R&D to revenue (%): 1.761938797559881
SG&A to revenue (%): 46.076029321321116
Free cash flow (dilution-adjusted): -31524264.70588235
Buyback yield (%): 7.606133960722454
Retained earnings: -215532352.94117644
Inventory turnover: 4.580769962580073
Receivables turnover: 0.9717493135196252
Capitalized R&D asset: 3897058.8235294116
ROCI (R&D-adjusted, %): 0.5493921323903296
FCF margin (%): -14.252755107129204
Rule of 40 score: -14.252755107129204
Financial ratios for IMAX — annual report dated 2023-12-31
Total revenue: 283968939.3939394
Gross profit: 162379545.45454544
Operating income: 40521212.12121212
Net income: 25050000
Capital expenditures: 18553787.87878788
Operating cash flow: 44405303.03030303
Depreciation & amortization: 45471212.12121212
Net tangible assets: 135240909.0909091
Owner earnings: 51967424.24242425
Return on net tangible assets (%): 38.42581700444774
Capex to operating income (%): 45.78784026323662
Buffett classification: The Good
Stock price: 15.02
P/E ratio: 32.88337534051896
Shares outstanding: 54842114
Book value: 261809848.4848485
P/B ratio: 3.1462855849277607
Market cap (USD): 823728552.28
Debt to equity: 0.7293490244191799
Current ratio: 1.969326556096875
Quick ratio: 1.830451835306119
Effective tax rate (%): 28.299759307847427
Interest coverage ratio: 7.84166544494942
COGS to revenue (%): 42.81784979684611
R&D to revenue (%): 2.6971579798260055
SG&A to revenue (%): 38.52480665032188
Free cash flow (dilution-adjusted): 1174242.4242424257
Buyback yield (%): 2.468266776177868
Retained earnings: -221852272.72727272
Inventory turnover: 5.081623606889565
Receivables turnover: 1.1436700421966677
Capitalized R&D asset: 10270120.320855616
ROCI (R&D-adjusted, %): 9.739269618909018
Rosenberg metric: 12.16626072041166
FCF margin (%): 0.4135108673323753
Revenue growth (%): 28.388077849689186
Rule of 40 score: 28.80158871702156
Financial ratios for IMAX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.51
Shares outstanding: 54842114
Market cap (USD): 1124811758.14
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMAX — annual report dated 2024-12-31
Total revenue: 246299300.6993007
Gross profit: 133006993.00699301
Operating income: 33294405.594405595
Net income: 22868531.46853147
Capital expenditures: 22915384.615384616
Operating cash flow: 49536363.63636364
Depreciation & amortization: 45806293.70629371
Net tangible assets: 141846853.14685315
Owner earnings: 45759440.55944056
Return on net tangible assets (%): 32.259750247730985
Capex to operating income (%): 68.82653168385457
Buffett classification: The Good
Stock price: 25.6
P/E ratio: 61.39257872032291
Shares outstanding: 54842114
Book value: 264486013.98601407
P/B ratio: 5.308250887225519
Market cap (USD): 1403958118.4
Debt to equity: 0.7039831841677351
Current ratio: 2.1772398110230213
Quick ratio: 2.020680679439934
Effective tax rate (%): 13.252692450527878
Interest coverage ratio: 5.88953488372093
COGS to revenue (%): 45.997819470313
R&D to revenue (%): 1.4488597646845047
SG&A to revenue (%): 37.67688411393268
Free cash flow (dilution-adjusted): 4483916.083916083
Buyback yield (%): 0.8951216352133646
Retained earnings: -192080419.5804196
Inventory turnover: 4.933252131546894
Receivables turnover: 1.1356163367693384
Capitalized R&D asset: 9986151.789387083
ROCI (R&D-adjusted, %): 7.167008365538899
Rosenberg metric: -3.8349920109564
FCF margin (%): 1.820515150138554
Revenue growth (%): -13.26540810239144
Rule of 40 score: -11.444892952252886
Financial ratios for IMAX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.6
Shares outstanding: 54842114
Market cap (USD): 1403958118.4
Buyback yield (%): 0.0065250088594374705
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMAX — quarterly report dated 2025-03-31
Total revenue: 60606293.70629371
Gross profit: 37186013.986013986
Operating income: 11741958.041958043
Net income: 5699300.6993007
Capital expenditures: 9364335.664335664
Operating cash flow: 4860839.160839161
Depreciation & amortization: 10428671.328671329
Net tangible assets: 140544755.24475524
Owner earnings: 6763636.363636363
Return on net tangible assets (%): 4.812443091069216
Capex to operating income (%): 79.75105711393007
Buffett classification: The Gruesome
Stock price: 26.35
P/E ratio: 63.388904189478524
Shares outstanding: 54842114
Book value: 268733566.43356645
P/B ratio: 5.377406786499224
Market cap (USD): 1445089703.9
Debt to equity: 0.7275722177840115
Current ratio: 2.1150572801850314
Quick ratio: 1.9717438834881282
Effective tax rate (%): 47.19792678976352
Interest coverage ratio: 9.323153803442533
COGS to revenue (%): 38.643312910334956
R&D to revenue (%): 1.5207633816793011
SG&A to revenue (%): 38.60985150057115
Free cash flow (dilution-adjusted): -9054545.454545455
Buyback yield (%): 0
Retained earnings: -190491608.3916084
Inventory turnover: 1.055665878644602
Receivables turnover: 0.26636280933823436
Capitalized R&D asset: 921678.3216783217
ROCI (R&D-adjusted, %): 2.8125036476754093
FCF margin (%): -14.939942538682544
Rule of 40 score: -14.939942538682544
Financial ratios for IMAX — quarterly report dated 2025-06-30
Total revenue: 66922627.73722627
Gross profit: 39125547.44525547
Operating income: 11045255.474452553
Net income: 8930656.93430657
Capital expenditures: 3854744.525547445
Operating cash flow: 16956204.379562043
Depreciation & amortization: 11602919.708029196
Net tangible assets: 162741605.83941606
Owner earnings: 16678832.11678832
Return on net tangible assets (%): 10.24865892821902
Capex to operating income (%): 34.899550621200106
Buffett classification: The Good
Stock price: 27.96
P/E ratio: 104.81134298827888
Shares outstanding: 54842114
Book value: 295673722.62773716
P/B ratio: 5.186072992257693
Market cap (USD): 1533385507.44
Debt to equity: 0.6863478928489434
Current ratio: 2.2242034519350247
Quick ratio: 2.057778644439809
Effective tax rate (%): 8.918335442566812
Interest coverage ratio: 7.852620653866113
COGS to revenue (%): 41.536145892413074
R&D to revenue (%): 1.6818637930282276
SG&A to revenue (%): 38.50399197242703
Free cash flow (dilution-adjusted): 6068613.138686131
Buyback yield (%): 0.06921376675752017
Retained earnings: -190701459.85401458
Inventory turnover: 1.0376849505436114
Receivables turnover: 0.2767008604272862
Capitalized R&D asset: 1743071.92077995
ROCI (R&D-adjusted, %): 2.419702489740133
Rosenberg metric: 2.1043496560814314
FCF margin (%): 9.068103485886306
Revenue growth (%): 10.421911066765391
Rule of 40 score: 19.490014552651697
Financial ratios for IMAX — quarterly report dated 2025-09-30
Total revenue: 76729496.4028777
Gross profit: 48396402.87769785
Operating income: 20895683.45323741
Net income: 16270503.597122304
Capital expenditures: 8771223.021582734
Operating cash flow: 48570503.597122304
Depreciation & amortization: 11227338.129496403
Net tangible assets: 180774100.7194245
Owner earnings: 18726618.705035973
Return on net tangible assets (%): 10.359127015711806
Capex to operating income (%): 41.97624375968325
Buffett classification: The Good
Stock price: 32.75
P/E ratio: 58.12467393573574
Shares outstanding: 54842114
Book value: 314177697.84172666
P/B ratio: 5.716762347672466
Market cap (USD): 1796079233.5
Debt to equity: 0.5889990313871772
Current ratio: 2.4367563286609863
Quick ratio: 2.2390721462581467
Effective tax rate (%): 18.708888968764604
Interest coverage ratio: 15.854257641921398
COGS to revenue (%): 36.92594745626043
R&D to revenue (%): 1.4111050687269115
SG&A to revenue (%): 32.084122489545635
Free cash flow (dilution-adjusted): 34891366.90647483
Buyback yield (%): 0
Retained earnings: -173096402.87769786
Inventory turnover: 0.950476650174973
Receivables turnover: 0.3427691753922495
Capitalized R&D asset: 2141004.4474246544
ROCI (R&D-adjusted, %): 4.260914178895156
Rosenberg metric: 8.236752232455288
FCF margin (%): 45.47321244397773
Revenue growth (%): 14.654040041820235
Rule of 40 score: 60.12725248579797
Financial ratios for IMAX — annual report dated 2025-12-31
Total revenue: 299424817.51824814
Gross profit: 179700729.9270073
Operating income: 68399270.0729927
Net income: 33230656.934306566
Capital expenditures: 26709489.05109489
Operating cash flow: 92750364.96350364
Depreciation & amortization: 45581021.89781021
Net tangible assets: 178216058.39416057
Owner earnings: 52102189.78102189
Return on net tangible assets (%): 29.235406871016888
Capex to operating income (%): 39.04937731439487
Buffett classification: The Good
Stock price: 36.96
P/E ratio: 60.99682403050566
Shares outstanding: 54842114
Book value: 312213868.6131386
P/B ratio: 6.492230926332082
Market cap (USD): 2026964533.44
Debt to equity: 0.6513666235712466
Current ratio: 2.4791721297015874
Quick ratio: 2.324196755076451
Effective tax rate (%): 28.07103471157948
Interest coverage ratio: 12.728470524314044
COGS to revenue (%): 39.984690842783735
R&D to revenue (%): 1.4178034772264096
SG&A to revenue (%): 33.75205991048531
Free cash flow (dilution-adjusted): 42575182.481751814
Buyback yield (%): 0.05235976511202012
Retained earnings: -175158394.1605839
Inventory turnover: 5.0460544531610525
Receivables turnover: 1.2761895873193647
Capitalized R&D asset: 9163671.558368638
ROCI (R&D-adjusted, %): 13.268003640208962
Rosenberg metric: 13.084860630143133
FCF margin (%): 14.218989205581503
Revenue growth (%): 21.569495596663003
Rule of 40 score: 35.788484802244504
Financial ratios for IMAX — quarterly report dated 2025-12-31
Total revenue: 91391970.8029197
Gross profit: 52657664.23357664
Operating income: 23897080.2919708
Net income: 1843065.6934306568
Capital expenditures: 4181021.897810219
Operating cash flow: 21440875.912408758
Depreciation & amortization: 11701459.854014598
Net tangible assets: 178216058.39416057
Owner earnings: 9363503.649635036
Return on net tangible assets (%): 5.254017922967283
Capex to operating income (%): 17.495952839121536
Buffett classification: The Great
Stock price: 36.96
P/E ratio: 61.90428227645747
Shares outstanding: 54842114
Book value: 312213868.6131386
P/B ratio: 6.492230926332082
Market cap (USD): 2026964533.44
Debt to equity: 0.6513666235712466
Current ratio: 2.4791721297015874
Quick ratio: 2.324196755076451
Effective tax rate (%): 61.76559660811629
Interest coverage ratio: 18.168146503884575
COGS to revenue (%): 42.38261439056921
R&D to revenue (%): 1.1588808932407932
SG&A to revenue (%): 28.330684386655697
Free cash flow (dilution-adjusted): 10556934.306569342
Buyback yield (%): 0
Retained earnings: -175158394.1605839
Inventory turnover: 1.6325488386402092
Receivables turnover: 0.3895250983869212
Capitalized R&D asset: 2155986.3992018066
ROCI (R&D-adjusted, %): 4.75784353991486
Rosenberg metric: 3.9356500230375553
FCF margin (%): 11.55127109506657
Revenue growth (%): 19.109306182663918
Rule of 40 score: 30.66057727773049
Financial ratios for IR5B.IR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.4772727272727275
Shares outstanding: 148432980
Market cap (USD): 664574933.1818182
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IR5B.IR — annual report dated 2022-12-31
Total revenue: 622234042.5531915
Gross profit: 472127659.57446814
Operating income: 70957446.80851065
Net income: 63617021.27659575
Capital expenditures: 76914893.61702128
Operating cash flow: 134361702.1276596
Depreciation & amortization: 64361702.12765958
Net tangible assets: 275425531.9148936
Owner earnings: 51063829.78723405
Return on net tangible assets (%): 18.539976825028972
Capex to operating income (%): 108.39580209895053
Buffett classification: The Gruesome
Stock price: 4.095744680851064
P/E ratio: 9.55630389632107
Shares outstanding: 148432980
Book value: 277446808.5106383
P/B ratio: 2.1912077185582826
Market cap (USD): 607943588.2978724
Debt to equity: 0.8055981595092025
Current ratio: 1.0615911035072711
Quick ratio: 1.0171086398631308
Effective tax rate (%): 4.319999999999999
Interest coverage ratio: 15.511627906976745
COGS to revenue (%): 24.123781843050093
Free cash flow (dilution-adjusted): 50638297.872340426
Buyback yield (%): 8.60942142320445
Retained earnings: 252553191.4893617
Inventory turnover: 27.134615384615383
Receivables turnover: 9.373397435897436
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.595185995623632
FCF margin (%): 8.138143272354249
Rule of 40 score: 8.138143272354249
Financial ratios for IR5B.IR — annual report dated 2023-12-31
Total revenue: 635555555.5555556
Gross profit: 469333333.3333333
Operating income: 76000000
Net income: 68444444.44444445
Capital expenditures: 42444444.44444444
Operating cash flow: 142888888.8888889
Depreciation & amortization: 71333333.33333333
Net tangible assets: 311333333.3333333
Owner earnings: 97333333.33333334
Return on net tangible assets (%): 31.26338329764454
Capex to operating income (%): 55.84795321637427
Buffett classification: The Good
Stock price: 4.466666666666666
P/E ratio: 9.686697720779218
Shares outstanding: 148432980
Book value: 313666666.6666667
P/B ratio: 2.113710873538788
Market cap (USD): 663000643.9999999
Debt to equity: 0.6748140276301806
Current ratio: 0.546203110704483
Quick ratio: 0.5279048490393412
Effective tax rate (%): 2.6856240126382307
Interest coverage ratio: 10.523076923076923
COGS to revenue (%): 26.15384615384615
Free cash flow (dilution-adjusted): 82777777.77777778
Buyback yield (%): 3.5863883380749444
Retained earnings: 285222222.2222222
Inventory turnover: 37.4
Receivables turnover: 9.811320754716983
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.283901888920216
FCF margin (%): 13.024475524475523
Revenue growth (%): 2.14091677589711
Rule of 40 score: 15.165392300372634
Financial ratios for IR5B.IR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 332812500
Buffett classification: The Gruesome
Stock price: 5.15625
Shares outstanding: 148432980
Book value: 335729166.66666675
P/B ratio: 2.2796874061433443
Market cap (USD): 765357553.125
Debt to equity: 0.6313993174061433
Current ratio: 1.0320460147904684
Quick ratio: 0.9408381265406738
Buyback yield (%): 0
Retained earnings: 305416666.6666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IR5B.IR — annual report dated 2024-12-31
Total revenue: 628958333.3333334
Gross profit: 467708333.3333334
Operating income: 71979166.66666667
Net income: 62395833.333333336
Capital expenditures: 26562500
Operating cash flow: 137291666.6666667
Depreciation & amortization: 67083333.333333336
Net tangible assets: 332812500
Owner earnings: 102916666.66666667
Return on net tangible assets (%): 30.923317683881063
Capex to operating income (%): 36.90303907380608
Buffett classification: The Good
Stock price: 5.15625
P/E ratio: 12.266164457429047
Shares outstanding: 148432980
Book value: 335729166.66666675
P/B ratio: 2.2796874061433443
Market cap (USD): 765357553.125
Debt to equity: 0.6313993174061433
Current ratio: 1.0320460147904684
Quick ratio: 0.9408381265406738
Effective tax rate (%): 3.697749196141479
Interest coverage ratio: 8.129411764705882
COGS to revenue (%): 25.637628353759524
Free cash flow (dilution-adjusted): 102395833.33333334
Buyback yield (%): 1.224917682163235
Retained earnings: 305416666.6666667
Inventory turnover: 13.945945945945946
Receivables turnover: 10.574430823117337
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.355237727097025
FCF margin (%): 16.280225240145743
Revenue growth (%): -1.0380244755244734
Rule of 40 score: 15.24220076462127
Financial ratios for IR5B.IR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 354117647.0588235
Buffett classification: The Gruesome
Stock price: 6.305882352941177
Shares outstanding: 148432980
Book value: 357529411.7647059
P/B ratio: 2.617968979269497
Market cap (USD): 936000909.1764706
Debt to equity: 0.7959855215531424
Current ratio: 0.5365853658536585
Quick ratio: 0.4620842572062083
Buyback yield (%): 0
Retained earnings: 320470588.2352941
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JSWCEMENT.NS — quarterly report dated 2025-09-30
Total revenue: 161942502.81848928
Gross profit: 126034949.26719278
Operating income: 21193912.06313416
Net income: 9744081.172491545
Capital expenditures: 0
Depreciation & amortization: 8966178.128523111
Net tangible assets: 574463359.6392334
Owner earnings: 18710259.301014654
Return on net tangible assets (%): 3.256997854965862
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.5488162344983087
P/E ratio: 53.29792449420918
Shares outstanding: 1341254801
Book value: 682218714.7688838
P/B ratio: 3.0450017940234133
Market cap (USD): 2077357210.3875985
Debt to equity: 0.7536190690234132
Current ratio: 0.8789921210702863
Quick ratio: 0.7165197493304211
Effective tax rate (%): 37.847422680412365
Interest coverage ratio: 1.8746509772636617
COGS to revenue (%): 22.173026182967494
SG&A to revenue (%): 22.859450164644294
Buyback yield (%): 0
Inventory turnover: 0.5097468070804392
Receivables turnover: 1.8989595864785902
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8324165889310307
Revenue growth (%): -18.961958996521712
Rule of 40 score: -18.961958996521712
Financial ratios for JSWCEMENT.NS — quarterly report dated 2025-12-31
Total revenue: 180597081.43032193
Gross profit: 134427982.62225688
Operating income: 22706917.678511754
Net income: 15828227.692993205
Capital expenditures: 0
Depreciation & amortization: 9045338.08622034
Owner earnings: 24873565.779213548
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.319148936170213
P/E ratio: 82.08617150509596
Shares outstanding: 1341254801
Market cap (USD): 1769314843.8723407
Effective tax rate (%): 29.122578544685005
Interest coverage ratio: 2.3505535055350553
COGS to revenue (%): 25.56469819025179
SG&A to revenue (%): 23.11962596069627
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 11.519260408579298
Rule of 40 score: 11.519260408579298
Financial ratios for KINGFA.NS — annual report dated 2022-03-31
Total revenue: 138166029.27601212
Gross profit: 20363404.9848345
Operating income: 10933495.97784518
Net income: 4039746.802057233
Capital expenditures: 2492654.622181195
Operating cash flow: 4990557.826717658
Depreciation & amortization: 1709745.4833179482
Net tangible assets: 50715811.68403007
Owner earnings: 3256837.6631939868
Return on net tangible assets (%): 6.421740193146775
Capex to operating income (%): 22.798331176342167
Buffett classification: The Great
Stock price: 16.642094157984967
P/E ratio: 55.82611228453257
Shares outstanding: 13551381
Book value: 50717051.2989582
P/B ratio: 4.446696974620074
Market cap (USD): 225523358.57272848
Debt to equity: 0.10896716845117652
Current ratio: 1.3001857611173187
Quick ratio: 0.74596487696405
Effective tax rate (%): 25.906056501547987
Interest coverage ratio: 20.976268184693232
COGS to revenue (%): 85.26164130825904
SG&A to revenue (%): 3.164540289182248
Free cash flow (dilution-adjusted): 2496676.7770011867
Buyback yield (%): 0
Retained earnings: 14627825.398918634
Inventory turnover: 3.4226238688601973
Receivables turnover: 3.7040534434860444
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.26581857371474
FCF margin (%): 1.807012034784335
Rule of 40 score: 1.807012034784335
Financial ratios for KINGFA.NS — annual report dated 2023-03-31
Total revenue: 170696394.6406821
Gross profit: 29594007.30816078
Operating income: 18034677.222898904
Net income: 9915992.691839222
Capital expenditures: 2981534.713763703
Operating cash flow: 3317795.371498173
Depreciation & amortization: 1722472.5943970769
Net tangible assets: 56758550.548112065
Owner earnings: 8656930.572472597
Return on net tangible assets (%): 15.252205154771254
Capex to operating income (%): 16.532232193088564
Buffett classification: The Great
Stock price: 16.00816077953715
P/E ratio: 21.87705180655273
Shares outstanding: 13551381
Book value: 56759110.8404385
P/B ratio: 3.821988798284864
Market cap (USD): 216932685.83276492
Debt to equity: 0.09105837156536706
Current ratio: 1.3681203164743867
Quick ratio: 0.8322251588572915
Effective tax rate (%): 25.715378073662045
Interest coverage ratio: 29.57449315889344
COGS to revenue (%): 82.66278126702295
SG&A to revenue (%): 3.5565492479257075
Free cash flow (dilution-adjusted): 329317.9049939099
Buyback yield (%): 0
Retained earnings: 23426029.23264312
Inventory turnover: 4.0073938445051045
Receivables turnover: 3.9162321251121983
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.443098102282597
FCF margin (%): 0.19292610467088533
Revenue growth (%): 23.544402003248262
Rule of 40 score: 23.737328107919147
Financial ratios for KINGFA.NS — annual report dated 2024-03-31
Total revenue: 178404556.9013071
Gross profit: 39840268.61734021
Operating income: 34113083.10348963
Net income: 14692708.957908623
Capital expenditures: 2502134.548507015
Operating cash flow: 1930938.9615061758
Depreciation & amortization: 2204341.0480873007
Net tangible assets: 70580261.42223288
Owner earnings: 14394915.457488906
Return on net tangible assets (%): 20.395100793654027
Capex to operating income (%): 7.3348238296615795
Buffett classification: The Great
Stock price: 23.380518234165066
P/E ratio: 21.564322241479772
Shares outstanding: 13551381
Book value: 70581112.84326658
P/B ratio: 4.48899567894592
Market cap (USD): 316838310.56861806
Debt to equity: 0.0552963517534442
Current ratio: 1.804148421822537
Quick ratio: 1.201975678183456
Effective tax rate (%): 25.380883474261438
Interest coverage ratio: 50.71923975252732
COGS to revenue (%): 80.8059483949755
SG&A to revenue (%): 3.931006705851576
Free cash flow (dilution-adjusted): -573689.8908742055
Buyback yield (%): 0
Retained earnings: 37763676.69984411
Inventory turnover: 4.9648735243683655
Receivables turnover: 3.68127249890382
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 48.02478450222416
FCF margin (%): -0.3215668371024677
Revenue growth (%): 4.515714744210489
Rule of 40 score: 4.194147907108021
Financial ratios for KINGFA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 77973268.03631152
Buffett classification: The Gruesome
Stock price: 40.34280936454849
Shares outstanding: 13551381
Book value: 77973877.20974678
P/B ratio: 7.011332511255791
Market cap (USD): 546700780.3093646
Debt to equity: 0.07010522255530162
Current ratio: 1.9370574432311585
Quick ratio: 1.2633953525611414
Buyback yield (%): 0
Retained earnings: 45285797.89775442
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KINGFA.NS — quarterly report dated 2024-12-31
Total revenue: 51331483.85592726
Gross profit: 11403928.196759528
Operating income: 9350845.086839957
Net income: 4036111.4348991723
Capital expenditures: 0
Depreciation & amortization: 639316.9367059098
Owner earnings: 4675428.371605082
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 41.15689474297703
P/E ratio: 34.546417414074185
Shares outstanding: 13551381
Market cap (USD): 557732761.4389788
Effective tax rate (%): 29.515915294845673
Interest coverage ratio: 54.48678937716498
COGS to revenue (%): 77.78375503664168
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KINGFA.NS — quarterly report dated 2025-03-31
Total revenue: 54892775.30979658
Gross profit: 12457937.806873975
Operating income: 10588040.682721533
Net income: 4898012.6256722
Capital expenditures: 0
Depreciation & amortization: 648784.1945288753
Net tangible assets: 85177215.33785363
Owner earnings: 5546796.820201075
Return on net tangible assets (%): 6.512066399681912
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 34.41825183802077
P/E ratio: 23.806331243733744
Shares outstanding: 13551381
Book value: 85177566.05097029
P/B ratio: 5.475794456628016
Market cap (USD): 466414844.01096976
Debt to equity: 0.0590200037358863
Current ratio: 2.0231299487701326
Quick ratio: 1.3098113675920635
Effective tax rate (%): 22.880992480926217
Interest coverage ratio: 36.177391651687635
COGS to revenue (%): 77.30495910151106
Buyback yield (%): 0
Retained earnings: 53184977.78816927
Inventory turnover: 1.205355414339305
Receivables turnover: 1.052587594806294
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.348634970826602
Revenue growth (%): 6.937830715871848
Rule of 40 score: 6.937830715871848
Financial ratios for KINGFA.NS — annual report dated 2025-03-31
Total revenue: 203961959.31727844
Gross profit: 46410591.53612345
Operating income: 39274397.942483045
Net income: 17869441.19710077
Capital expenditures: 3542868.833294365
Operating cash flow: 7005284.077624503
Depreciation & amortization: 2538543.3715220946
Net tangible assets: 85177215.33785363
Owner earnings: 16865115.7353285
Return on net tangible assets (%): 19.800031814181025
Capex to operating income (%): 9.020810041398624
Buffett classification: The Great
Stock price: 34.41825183802077
P/E ratio: 26.101255146503593
Shares outstanding: 13551381
Book value: 85177566.05097029
P/B ratio: 5.475794456628016
Market cap (USD): 466414844.01096976
Debt to equity: 0.0590200037358863
Current ratio: 2.0231299487701326
Quick ratio: 1.3098113675920635
Effective tax rate (%): 25.82707159130335
Interest coverage ratio: 50.479805265055894
COGS to revenue (%): 77.24546690398859
SG&A to revenue (%): 3.863630605908005
Free cash flow (dilution-adjusted): 3459632.920271218
Buyback yield (%): 0
Retained earnings: 53184977.78816927
Inventory turnover: 4.475223787024022
Receivables turnover: 3.911039785802896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 45.805000039539586
FCF margin (%): 1.6962147901754043
Revenue growth (%): 14.325532295741539
Rule of 40 score: 16.021747085916942
Financial ratios for KINGFA.NS — quarterly report dated 2025-06-30
Total revenue: 54052691.31757548
Gross profit: 12056283.641469695
Operating income: 6039269.833840393
Net income: 4656096.419377487
Capital expenditures: 0
Depreciation & amortization: 738368.8275216476
Owner earnings: 5394465.2468991345
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 40.370933770184884
P/E ratio: 40.25555771171715
Shares outstanding: 13551381
Market cap (USD): 547081904.8455418
Effective tax rate (%): 26.400873031286704
Interest coverage ratio: 43.24028150134048
COGS to revenue (%): 77.69531294818333
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -1.5304090337570786
Rule of 40 score: -1.5304090337570786
Financial ratios for KINGFA.NS — quarterly report dated 2025-09-30
Total revenue: 52501589.627959415
Gross profit: 12610124.013528747
Operating income: 6022063.13416009
Net income: 4638534.385569335
Capital expenditures: 0
Depreciation & amortization: 809413.7542277339
Net tangible assets: 145950202.93122885
Owner earnings: 5447948.139797069
Return on net tangible assets (%): 3.7327444774873797
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 51.23111612175873
P/E ratio: 38.085562000422414
Shares outstanding: 13551381
Book value: 145950450.95828637
P/B ratio: 4.756767581482958
Market cap (USD): 694252373.621195
Debt to equity: 0.014377553191941325
Current ratio: 2.9374926064860802
Quick ratio: 2.184541871314016
Effective tax rate (%): 25.70518480798713
Interest coverage ratio: 64.54289511841469
COGS to revenue (%): 75.98144341364228
Buyback yield (%): 0
Retained earnings: 60374656.14430665
Inventory turnover: 1.1096095921877671
Receivables turnover: 1.0686263733615982
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.074131362948597
Revenue growth (%): -2.8696104704627614
Rule of 40 score: -2.8696104704627614
Financial ratios for KINGFA.NS — quarterly report dated 2025-12-31
Total revenue: 54523738.44268687
Gross profit: 13261913.77965913
Operating income: 11069856.299431883
Net income: 5032237.941405815
Capital expenditures: 0
Depreciation & amortization: 822022.9475325833
Owner earnings: 5854260.888938398
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 49.46418625375961
P/E ratio: 34.86669284498476
Shares outstanding: 13551381
Market cap (USD): 670308033.7796592
Effective tax rate (%): 25.61509354427587
Interest coverage ratio: 119.67015895953757
COGS to revenue (%): 75.67680764663723
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 3.8515954070285368
Rule of 40 score: 3.8515954070285368
Financial ratios for KMX — annual report dated 2022-02-28
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 109.33
Shares outstanding: 141911096
Market cap (USD): 15515140125.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KMX — annual report dated 2023-02-28
Total revenue: 29684873000
Gross profit: 2800203000
Operating income: -310946000
Net income: 484762000
Capital expenditures: 5190000
Operating cash flow: 1283332000
Depreciation & amortization: 265224000
Net tangible assets: 5471819000
Owner earnings: 744796000
Return on net tangible assets (%): 13.611488245499348
Buffett classification: The Gruesome
Stock price: 69.04
P/E ratio: 20.21103565840557
Shares outstanding: 141911096
Book value: 5613077000
P/B ratio: 1.7454850642241324
Market cap (USD): 9797542067.84
Debt to equity: 3.3727882229301325
Current ratio: 2.6009071815616793
Quick ratio: 0.6785417819947367
Effective tax rate (%): 23.875792237485946
Interest coverage ratio: -0.7219583095347553
COGS to revenue (%): 90.56690254325831
SG&A to revenue (%): 8.590907564266823
Free cash flow (dilution-adjusted): 775030000
Buyback yield (%): 3.4083242275235244
Retained earnings: 3723094000
Inventory turnover: 7.2151490737604735
Receivables turnover: 99.35261711677036
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.282546399842438
FCF margin (%): 2.6108583991583862
Rule of 40 score: 2.6108583991583862
Financial ratios for KMX — annual report dated 2024-02-29
Total revenue: 26536040000
Gross profit: 2713209000
Operating income: -205719000
Net income: 479204000
Capital expenditures: 1351000
Operating cash flow: 458617000
Depreciation & amortization: 260414000
Net tangible assets: 5932482000
Owner earnings: 738267000
Return on net tangible assets (%): 12.444487821454832
Buffett classification: The Gruesome
Stock price: 79
P/E ratio: 23.394997921553244
Shares outstanding: 141911096
Book value: 6073740000
P/B ratio: 1.84581107917033
Market cap (USD): 11210976584
Debt to equity: 3.1793385953300604
Current ratio: 2.2603549988777356
Quick ratio: 0.6696931049708752
Effective tax rate (%): 25.310515200399003
Interest coverage ratio: -0.2694596895670967
COGS to revenue (%): 89.77538095360121
SG&A to revenue (%): 8.866809064200988
Free cash flow (dilution-adjusted): -126410000
Buyback yield (%): 0.8392310812090801
Retained earnings: 4126909000
Inventory turnover: 6.476992281277953
Receivables turnover: 119.98950952507992
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8266950666655736
FCF margin (%): -0.47637100335995874
Revenue growth (%): -10.60753401235707
Rule of 40 score: -11.083905015717027
Financial ratios for KMX — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 84.55
Shares outstanding: 141911096
Market cap (USD): 11998583166.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KMX — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 83.97
Shares outstanding: 141911096
Market cap (USD): 11916274731.119999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0